 |
|
|
| |
High Efficacy of Ledipasvir/Sofosbuvir Plus Ribavirin Among Patients With Decompensated Cirrhosis Who Underwent Liver Transplant During Participation in the SOLAR-1 and SOLAR-2 Studies
|
| |
| |
Reported by Jules Levin
DDW 2016 May 22-24 San Diego, CA
Paul Y. Kwo1, Beat Mullhaupt2, Kosh Agarwal3, Christope Durvous4, Francois Durand5, Marcus Peck-Radosavljevic6, Eric M. Yoshida7, Leslie Lilly8, Bernard Willems9, Hugo E. Vargas10, Princy Kumar11, Robert S. Brown12,
Yves Horsmans 13, Shampa De-Oertel14, Sarah Arterburn14, Macky Natha14, Stacey M. Lee14, Hadas Dvory-Sobol14, Diana M. Brainard14, John G. McHutchison14, Norah A. Terrault15, Mario Rizzetto16
1Indiana University School of Medicine, Indianapolis, Indiana, USA; 2University Hospital Zurich, Switzerland; 3The Institute of Liver Studies, King's College London, UK; 4Hopital Henri Mondor, Universite Paris-Est Creteil, Creteil, France; 5Hopital Beaujon, Clichy, Assistance Publique-Hopitaux de Paris, Universite Paris Diderot-Paris 7, France; 6Medical University of Vienna, Austria; 7Vancouver General Hospital, University of British Columbia, Vancouver, Canada;
8Toronto General Hospital, University Health Network, Toronto, Ontario, Canada; 9Centre Hospitalier de l'Universite de Montreal, Quebec, Canada; 10Mayo Clinic, Phoenix, Arizona, USA; 11Georgetown University, Washington, DC, USA; 12Columbia University Medical Center/New York-Presbyterian, New York, New York, USA; 13Universite Catholique de Louvain, Belgium; 14Gilead Sciences, Inc., Foster City, California, USA; 15University of California, San Francisco; 16L'Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino, Italy
- Sa1637
|
| |
|
|
|
|
|
